Literature DB >> 10646652

A cell line for high-yield production of E1-deleted adenovirus vectors without the emergence of replication-competent virus.

G P Gao1, R K Engdahl, J M Wilson.   

Abstract

Production of E1-deleted adenovirus vectors for gene therapy has been plagued by the emergence of replication-competent adenovirus. A number of investigators have minimized homologous sequences between the vector and transfected E1 DNA in an attempt to avoid replication-competent adenovirus. We describe a HeLa-based cell line called GH329 that stably expresses the E1 locus from a promoter derived from the phosphoglycerate kinase gene. Overlap sequences with a standard E1-deleted vector that retains a full pIX transcriptional unit have been eliminated at the 5' end and minimized at the 3' end. The GH329 cell line plaques and produces E1-deleted adenovirus as well as 293 cells. Replication-competent virus has emerged after 5 passages of vector on 293 cells but was not detected after 20 passages on GH329 cells.

Mesh:

Year:  2000        PMID: 10646652     DOI: 10.1089/10430340050016283

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  6 in total

1.  Feasibility of generating adeno-associated virus packaging cell lines containing inducible adenovirus helper genes.

Authors:  Chunping Qiao; Juan Li; Anna Skold; Xudong Zhang; Xiao Xiao
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

Review 2.  Adenoviral vectors for gene therapy.

Authors:  Joanne T Douglas
Journal:  Mol Biotechnol       Date:  2007-05       Impact factor: 2.860

3.  Adenoviral producer cells.

Authors:  Imre Kovesdi; Susan J Hedley
Journal:  Viruses       Date:  2010-08-16       Impact factor: 5.818

4.  Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein.

Authors:  Yan Zhi; Gary P Kobinger; Heather Jordan; Katie Suchma; Susan R Weiss; Hao Shen; Gregory Schumer; Guangping Gao; Julie L Boyer; Ronald G Crystal; James M Wilson
Journal:  Virology       Date:  2005-04-25       Impact factor: 3.616

5.  Adenovirus-based vaccine prevents pneumonia in ferrets challenged with the SARS coronavirus and stimulates robust immune responses in macaques.

Authors:  Gary P Kobinger; Joanita M Figueredo; Thomas Rowe; Yan Zhi; Guangping Gao; Julio C Sanmiguel; Peter Bell; Nelson A Wivel; Lois A Zitzow; Douglas B Flieder; Robert J Hogan; James M Wilson
Journal:  Vaccine       Date:  2007-05-07       Impact factor: 3.641

Review 6.  Viral vaccines and their manufacturing cell substrates: New trends and designs in modern vaccinology.

Authors:  Ana F Rodrigues; Hugo R Soares; Miguel R Guerreiro; Paula M Alves; Ana S Coroadinha
Journal:  Biotechnol J       Date:  2015-07-24       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.